European Pharmaceutical Review

DECEMBER 4, 2023

However, the knowledge generated using a PAT framework can help to seamlessly transfer these insights to pilot testing and manufacturing operations. The result is efficient, cost-effective and high-quality (bio)pharmaceutical production. In April 2022 both companies were acquired by Bruker.

Pharmaceutical manufacturing 87

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 87

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6%

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme. April 2022.

Management 74

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 74

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1]

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

JULY 21, 2023

A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. What are the top three supply-related challenges facing pharmaceutical manufacturers?

Pharmaceutical 93

Pharmaceutical Food and Drug Administration Transportation Manufacturing 93

pharmaphorum

OCTOBER 27, 2022

Libby Amos-Stone, Counsel, acts for life sciences companies in product liability and public law litigation before the UK and EU Courts, and advises clients on the pharmaceutical, medical device, food, cosmetic, and cannabis regulatory framework in the UK and EU.

Media 88

Media Pharmaceutical Medicine Electronics 88

European Pharmaceutical Review

JULY 25, 2022

.” These products are disguised as legitimate branded medicines and it can be difficult for those across the supply chain, as well as patients, to detect counterfeit products from authentic originals. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.

Pharmaceutical 80

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 80